Sprint Bioscience Financials
| SPRINT Stock | SEK 1.64 0.12 7.89% |
Sprint |
Please note, the presentation of Sprint Bioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sprint Bioscience's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sprint Bioscience's management manipulating its earnings.
Sprint Bioscience Stock Summary
Sprint Bioscience competes with Cantargia, Saniona AB, Acarix AS, Gabather, and Lidds AB. Sprint Bioscience AB develops pharmaceutical products in the areas of cancer and metabolism. Sprint Bioscience AB was founded in 2009 and is based in Huddinge, Sweden. Sprint Bioscience operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0006343745 |
| Business Address | Novum, Huddinge, Sweden, |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.sprintbioscience.com |
| Phone | 46 84 11 44 55 |
| Currency | SEK - Swedish Kronor |
You should never invest in Sprint Bioscience without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Sprint Stock, because this is throwing your money away. Analyzing the key information contained in Sprint Bioscience's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Sprint Bioscience Key Financial Ratios
Sprint Bioscience's financial ratios allow both analysts and investors to convert raw data from Sprint Bioscience's financial statements into concise, actionable information that can be used to evaluate the performance of Sprint Bioscience over time and compare it to other companies across industries.Sprint Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sprint Bioscience's current stock value. Our valuation model uses many indicators to compare Sprint Bioscience value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sprint Bioscience competition to find correlations between indicators driving Sprint Bioscience's intrinsic value. More Info.Sprint Bioscience AB is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sprint Bioscience by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sprint Bioscience's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sprint Bioscience Systematic Risk
Sprint Bioscience's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sprint Bioscience volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-one with a total number of output elements of fourty. The Beta measures systematic risk based on how returns on Sprint Bioscience correlated with the market. If Beta is less than 0 Sprint Bioscience generally moves in the opposite direction as compared to the market. If Sprint Bioscience Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sprint Bioscience is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sprint Bioscience is generally in the same direction as the market. If Beta > 1 Sprint Bioscience moves generally in the same direction as, but more than the movement of the benchmark.
Sprint Bioscience February 18, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sprint Bioscience help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sprint Bioscience AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sprint Bioscience AB based on widely used predictive technical indicators. In general, we focus on analyzing Sprint Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sprint Bioscience's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.87 | |||
| Information Ratio | 0.0531 | |||
| Maximum Drawdown | 18.41 | |||
| Value At Risk | (6.51) | |||
| Potential Upside | 7.89 |
Complementary Tools for Sprint Stock analysis
When running Sprint Bioscience's price analysis, check to measure Sprint Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sprint Bioscience is operating at the current time. Most of Sprint Bioscience's value examination focuses on studying past and present price action to predict the probability of Sprint Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sprint Bioscience's price. Additionally, you may evaluate how the addition of Sprint Bioscience to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |